Loading...
JBS is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock is currently trading pre-market at $15.55, which is below the analysts' average price target of $19.50, implying a 23% upside. Positive catalysts such as the company's expansion into the Middle East and the U.S. listing re-rating potential make it an attractive long-term investment. While short-term technical indicators are mixed, the long-term growth potential outweighs these concerns.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 47.93, suggesting no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. Key support is at $15.599, and resistance is at $16.241. The pre-market price of $15.55 is near support, presenting a potential entry point.

UBS initiated coverage with a Buy rating and a $19.50 price target, implying a 23% upside.
JBS's $150 million investment in a Middle Eastern food company expands its halal food operations and establishes a local production base.
The U.S. listing and potential inclusion in indices could drive a re-rating over the next two years.
Q3 financials showed a decline in net income (-16.17% YoY), EPS (-16.13% YoY), and gross margin (-20.11% YoY), which may concern some investors.
MACD indicates bearish momentum in the short term.
In Q3 2025, revenue increased by 13.40% YoY to $22.6 billion, showcasing strong top-line growth. However, net income dropped by 16.17% YoY to $580.9 million, and EPS fell by 16.13% to $0.52. Gross margin also declined by 20.11% to 13.15%, indicating cost pressures.
Analysts are bullish on JBS, with UBS initiating coverage with a Buy rating and a $19.50 price target. Other analysts, including Grupo Santander and BofA, have also issued Buy or Outperform ratings with price targets ranging from $17 to $21. Goldman Sachs recently lowered its price target to $18.50 but maintained a Buy rating.